Monitoring and Population HealthPopulation Medicines Surveillance
From practice-wide cohorts to named patients.
Across the practice, high-risk medicines carry monitoring and review obligations; Reedley groups patients by what is due or outstanding and opens each as owned work; clinicians decide.
- Cohorts for high-risk medicines and shared-care monitoring.
- Patients due for review and recalls outstanding, in a prioritised queue.
- Every cohort entry opens into the individual patient’s workflow.
Interactive demonstration
Synthetic practice data · pause, step and replay at any point
Synthetic practice data · small, made-up counts
Step 1 of 6 · A synthetic practice list · Continues as you scroll
- A synthetic practice list
- Cohorts from draft rules
- Each rule and its sign-off
- Prioritised work queue
- Open one cohort
- One patient’s workflow
Synthetic Practice
Select a cohort to see its items and where they sit in the queue.
How this view is built
Draft rules first run across the synthetic practice list on 26 Oct 2026, so several items were already past due when found.
- Synthetic practice listas at 31 Oct 2026 09:00
- Draft rule table7 rules · draft · unsigned
- Cohorts7 cohorts counted
- Work queue26 items need work
- One patient’s workflowOwned, evidenced work
The 7 draft rules
- Methotrexate · blood monitoring“FBC, LFT and U&E every 12 weeks while on a stable dose of methotrexate.”Practice monitoring rule · draft · unsigned
- Lithium · lithium level“Lithium level every 6 months after the first year (draft; 3-monthly for the groups a clinician applies).”Practice monitoring rule · draft · unsigned
- DOACs · renal function older than the draft interval“Renal function (serum creatinine for creatinine clearance), FBC and LFTs at least every 12 months while on a DOAC; more often for people over 75 or frail, or with creatinine clearance below 60 mL/min (draft, after SPS DOAC monitoring, updated 22 Oct 2026). The interval for each patient is set by a clinician.”Practice monitoring rule · draft · unsigned
- Shared-care agreements · due for review“Shared-care agreement listed for review 30 days before its review date.”Practice monitoring rule · draft · unsigned · Illustrative: shared care is not built
- Structured medication reviews due“Structured medication review offered at least every 12 months to patients with 10 or more repeat medicines.”Practice monitoring rule · draft · unsigned
- Recalls outstanding“A timed review is outstanding from the start of its window until an attendance or a review is recorded.”Practice monitoring rule · draft · unsigned
- Record patterns for a clinician’s review“Methotrexate on repeat with no folic acid on repeat: listed for a clinician’s review.”Practice monitoring rule · draft · unsigned
Items needing work, by cohort · 26 in all
Show as a table
| Cohort | Items needing work |
|---|---|
| Methotrexate · blood monitoring | 3 |
| Lithium · lithium level | 1 |
| DOACs · renal function older than the draft interval | 4 |
| Shared-care agreements · due for review | 2 |
| Structured medication reviews due | 11 |
| Recalls outstanding | 4 |
| Record patterns for a clinician’s review | 1 |
| Total | 26 |
Prioritised work queue · 26 items
Ordered by a stated rule, not a score: past due first, oldest due date first; then due soonest; items with no due date last.
Due dates follow the draft rules.
- 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not readOpen workflow for Ronald GIBBS →
- 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
- 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
- 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
- 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
- 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
- 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
- 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
Showing 8 of 26 items needing work. Further down: 7 more past due · 10 due soon · 1 with no due date.
Methotrexate · blood monitoring
7 patients · 3 in the work queue
Rule
“FBC, LFT and U&E every 12 weeks while on a stable dose of methotrexate.”
Practice monitoring rule · draft · unsigned
Sign-off: draft · unsigned · no named clinical owner yet
How the 7 patients divide
- Monitoring within the 12-week interval4Counted, not queued
- Due within 14 days2In the work queue
- Past due1In the work queue
Where its items sit in the prioritised queue
Due dates follow the draft rules.
- 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
- 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
- 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
- 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
- 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
- 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksThis cohortDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
- 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
- 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
- 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
1 of its 3 items is among the first 8 of 26. Further down the queue: 2 due soon.
Lithium · lithium level
3 patients · 1 in the work queue
Rule
“Lithium level every 6 months after the first year (draft; 3-monthly for the groups a clinician applies).”
Practice monitoring rule · draft · unsigned
Sign-off: draft · unsigned · no named clinical owner yet
How the 3 patients divide
- Level within the draft interval2Counted, not queued
- Past due1In the work queue
Where its items sit in the prioritised queue
Due dates follow the draft rules.
- 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
- 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)This cohortDue 4 Sep 2026Past dueAssignedadmin team
- 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
- 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
- 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
- 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
- 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
- 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
- 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
Its 1 item is among the first 8 of 26.
DOACs · renal function older than the draft interval
31 patients · 4 in the work queue
Rule
“Renal function (serum creatinine for creatinine clearance), FBC and LFTs at least every 12 months while on a DOAC; more often for people over 75 or frail, or with creatinine clearance below 60 mL/min (draft, after SPS DOAC monitoring, updated 22 Oct 2026). The interval for each patient is set by a clinician.”
Practice monitoring rule · draft · unsigned
Sign-off: draft · unsigned · no named clinical owner yet
How the 31 patients divide
- U&E within 12 months27Counted, not queued
- U&E older than 12 months4In the work queue
Where its items sit in the prioritised queue
Due dates follow the draft rules.
- 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanThis cohortDue 3 Sep 2026Past dueActionedinvitation sent, not readOpen workflow for Ronald GIBBS →
- 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
- 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
- 4Peter LOMAXNo U&E in the last 12 months while on apixabanThis cohortDue 20 Sep 2026Past dueAssignedadmin team
- 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
- 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
- 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
- 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
- 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not readOpen workflow for Ronald GIBBS →
- 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
2 of its 4 items are among the first 8 of 26. Further down the queue: 2 more past due.
Shared-care agreements · due for review
9 agreements · 2 in the work queue
Rule
“Shared-care agreement listed for review 30 days before its review date.”
Practice monitoring rule · draft · unsigned · Illustrative: shared care is not built
Sign-off: draft · unsigned · no named clinical owner yet
How the 9 agreements divide
- Review date within 30 days2In the work queue
- Review date later7Counted, not queued
Where its items sit in the prioritised queue
Due dates follow the draft rules.
- 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
- 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
- 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
- 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
- 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
- 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
- 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
- 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
None of its 2 items are among the first 8 of 26: past-due items come first. Further down the queue: 2 due soon.
Structured medication reviews due
46 patients · 11 in the work queue
Rule
“Structured medication review offered at least every 12 months to patients with 10 or more repeat medicines.”
Practice monitoring rule · draft · unsigned
Sign-off: draft · unsigned · no named clinical owner yet
How the 46 patients divide
- Review recorded in the last 12 months35Counted, not queued
- Due within 30 days6In the work queue
- Past due5In the work queue
Where its items sit in the prioritised queue
Due dates follow the draft rules.
- 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
- 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
- 3Margaret DUNNENo structured medication review in 12 monthsThis cohortDue 12 Sep 2026Past dueIdentifiedawaiting review
- 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
- 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
- 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
- 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
- 8Raymond PIKENo structured medication review in 12 monthsThis cohortDue 18 Oct 2026Past dueIdentifiedawaiting review
- 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
- 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
2 of its 11 items are among the first 8 of 26. Further down the queue: 3 more past due · 6 due soon.
Recalls outstanding
9 recalls · 4 in the work queue
Rule
“A timed review is outstanding from the start of its window until an attendance or a review is recorded.”
Practice monitoring rule · draft · unsigned
Sign-off: draft · unsigned · no named clinical owner yet
How the 9 recalls divide
- Inside their window5Counted, not queued
- Past their window, no attendance recorded4In the work queue
Inside-window recalls are counted but not queued: booked is not attended, and the window has not ended.
Where its items sit in the prioritised queue
Due dates follow the draft rules.
- 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
- 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
- 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
- 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
- 5Sandra KEMPHypertension review window ended, no attendance recordedThis cohortDue 30 Sep 2026Past dueActionedinvitation sent, not read
- 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
- 7Graham WEBBAsthma review window ended, no attendance recordedThis cohortDue 15 Oct 2026Past dueIdentifiedawaiting review
- 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
- 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
- 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
2 of its 4 items are among the first 8 of 26. Further down the queue: 2 more past due.
Record patterns for a clinician’s review
1 patient · 1 in the work queue
Rule
“Methotrexate on repeat with no folic acid on repeat: listed for a clinician’s review.”
Practice monitoring rule · draft · unsigned
Sign-off: draft · unsigned · no named clinical owner yet
The patient counted
- Methotrexate on repeat without folic acid on repeat1In the work queue
Listed for a clinician to look at. Reedley does not judge whether a prescription is appropriate.
Where its items sit in the prioritised queue
Due dates follow the draft rules.
- 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
- 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
- 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
- 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
- 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
- 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
- 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
- 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
Its 1 item is not among the first 8 of 26: past-due items come first. Further down the queue: 1 with no due date.
One patient’s workflow
From the cohort: DOACs · renal function older than the draft interval
Work history
- IdentifiedReedley · draft rule“Identified: no U&E in the last 12 months while on rivaroxaban (draft rule)”Reedley work history · 26 Oct 2026 07:00
- ReviewedR. SHAH, clinical pharmacist“Reviewed by R. SHAH: evidence opened; item accepted.”Reedley work history · 26 Oct 2026 10:05
- AssignedR. SHAH“Assigned: admin team · due 14 Nov.”Reedley work history · 26 Oct 2026 10:06
- ActionedAdmin team · reported, not proven“Actioned: invitation sent by text (delivered, not read).”Reedley work history · 27 Oct 2026 09:30
- VerifiedNot reachedVerified only when a U&E result is received in the record; open until a clinician’s review of it is recorded.
On the record
- On the record: rivaroxaban 20 mg once daily with food.E1medication record · as at 26 Oct 2026
- Latest U&E received 3 Sep 2025, as reported.E2Result · received 3 Sep 2025 15:30
Synthetic record
The passages cited above
Current medication
Rivaroxaban 20mg tablets · 20 mg once daily with food
U&E result
U&E: Na 138 mmol/L, K 4.4 mmol/L, creatinine 101 µmol/L, eGFR 63 mL/min/1.73m² · no laboratory flag
Actioned Actioned · awaiting evidence · sent is not read
See this item in My Day on 12 Nov →Synthetic practice data. Population views are not in the development build; the rules are drafts with no named clinical owner.
Illustrative demonstration · intended workflow · Scripted reconstruction: the development build itself is not running on this page.
From what arrives to what you decide
- What entersMonitoring and review obligations across the practice
- What Reedley preparesPatients grouped by what is due or outstanding, each opening as owned work
- What the clinician decidesClinicians decide
What it does not do · what exists today
- Reedley contacts no patient: each cohort entry becomes work for a named clinician.
- Population runs would need bulk read access through a supplier route.
- The rules behind every cohort are drafts awaiting a named clinical owner.
- Not yet in Reedley’s intended-purpose register: shown to explore the workflow, not as committed product scope.
Every patient shown is synthetic. No integration with a clinical system is claimed, and no clinician has yet used Reedley in practice. Safety and governance
See it with your own work in mind.
Tell us your role and the workflows you care about, and we will walk you through them on synthetic data.